304 related articles for article (PubMed ID: 32355188)
1. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
[TBL] [Abstract][Full Text] [Related]
2. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.
Kanojia G; Raeven RHM; van der Maas L; Bindels THE; van Riet E; Metz B; Soema PC; Ten Have R; Frijlink HW; Amorij JP; Kersten GFA
J Control Release; 2018 Sep; 286():167-178. PubMed ID: 30048656
[TBL] [Abstract][Full Text] [Related]
3. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T
Allen AC; Wilk MM; Misiak A; Borkner L; Murphy D; Mills KHG
Mucosal Immunol; 2018 Nov; 11(6):1763-1776. PubMed ID: 30127384
[TBL] [Abstract][Full Text] [Related]
4. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination.
Raeven RH; Brummelman J; Pennings JLA; van der Maas L; Helm K; Tilstra W; van der Ark A; Sloots A; van der Ley P; van Eden W; Jiskoot W; van Riet E; van Els CA; Kersten GF; Han WG; Metz B
Mucosal Immunol; 2018 May; 11(3):979-993. PubMed ID: 28930286
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine.
Raeven RH; Brummelman J; Pennings JL; van der Maas L; Tilstra W; Helm K; van Riet E; Jiskoot W; van Els CA; Han WG; Kersten GF; Metz B
Sci Rep; 2016 Dec; 6():38240. PubMed ID: 27905535
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
9. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
Roberts M; Cropley I; Chatfield S; Dougan G
Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
[TBL] [Abstract][Full Text] [Related]
11. Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant.
Shi W; Kou Y; Jiang H; Gao F; Kong W; Su W; Xu F; Jiang C
Immunol Lett; 2018 Jun; 198():26-32. PubMed ID: 29601940
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
[No Abstract] [Full Text] [Related]
13. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
Feunou PF; Kammoun H; Debrie AS; Locht C
Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
Orr B; Douce G; Baillie S; Parton R; Coote J
Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin Clears
Borkner L; Misiak A; Wilk MM; Mills KHG
Front Immunol; 2018; 9():1764. PubMed ID: 30105030
[TBL] [Abstract][Full Text] [Related]
16. The Role of Mucosal Immunity in Pertussis.
Solans L; Locht C
Front Immunol; 2018; 9():3068. PubMed ID: 30692990
[TBL] [Abstract][Full Text] [Related]
17. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
Torkashvand A; Bahrami F; Adib M; Ajdary S
Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
[TBL] [Abstract][Full Text] [Related]
18. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
Front Immunol; 2022; 13():878832. PubMed ID: 35493458
[TBL] [Abstract][Full Text] [Related]
20. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL
Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
